March 5, 2013 – The World Health Organization (WHO) and International Agency for Research on Cancer (IARC) has released a joint statement affirming that all forms of asbestos are found to cause cancer in humans. The statement declares that there is no safe form of asbestos, and the only way to eliminate the risk of […]
March 5, 2013 – On March 15, 2013, the 12th Annual Penn Presbyterian Benefit – “Mad Party” – will be held at Vie in Philadelphia. The theme of the event is inspired by the hit AMC TV show, Mad Men, and attendees are encouraged to wear their vintage attire. The evening festivities will include a […]
February 26, 2013 – When members of the Mesothelioma community – medical experts, advocates, patients and caregivers – gather at the 10th annual Meso Foundation Symposium, “All in for a Cure”, presented by the Mesothelioma Applied Research Foundation (MARF) on March 7th and 8th, 2013, in Las Vegas, two very special women will be recognized […]
February 1, 2013 – Early detection of cancer offers patients more therapy options and better outcomes. Cancer screening is an important diagnostic tool to detect tumors at their earliest stages; however, not all types of cancer, including mesothelioma, have effective screening tests. For that reason, researchers continue to work toward development of new and more […]
February 1, 2013 – The Shein Law is proud to be a Silver Sponsor of the 10th annual Meso Foundation Symposium, “All In for a Cure”, presented by the Mesothelioma Applied Research Foundation. The Mesothelioma Applied Research Foundation (MARF) – through support, research, and awareness – brings together mesothelioma patients and their families, physicians, advocates, […]
January 17, 2013 – Clinical trials are crucial in developing cutting edge treatments and therapies for cancer sufferers. They can be a “lifeline” to victims of mesothelioma, an asbestos-related cancer with no known cure. Clinical trial participants have access to advanced treatments that are not yet available to the general public. Moreover, mesothelioma patients who […]
January 17, 2013 – The Philadelphia mesothelioma attorneys at the Shein Law are pleased to report that Morphotek Inc. has recently announced that their investigational cancer drug, Amatuximab, has received a designation of orphan drug status from the Food and Drug Administration (FDA) for the treatment of malignant pleural mesothelioma. Malignant pleural mesothelioma is the most […]
January 7, 2013 – Benjamin P. Shein, Esquire of Shein Law in Philadelphia has been selected as one of the Top 100 Litigation Lawyers in the State of Pennsylvania for 2013 by the American Society of Legal Advocates (ASLA). This “invitation-only” legal association limits their selection to the nation’s most skilled attorneys by choosing no […]
January 3, 2013 – Philadelphia asbestos attorneys, Benjamin Shein and Bethann Schaffzin Kagan of the Shein Law, were recently admitted as members to the National Asbestos/Mesothelioma Trial Lawyers Association. Through informative programs, publications and resources, this Specialty Association’s mission is to assist its members to be the strongest and most effective asbestos trial lawyers in […]
December 26, 2012 – Researchers at the University of Pennsylvania’s Abramson Cancer Center continue to work on a new approach to treating leukemia using genetically engineered T cell immunotherapy. The promising treatment involves a gene therapy technique utilizing the sick patient’s own immune cells, which are called T cells, to fight cancer cells. In this […]
